The latest developments and news items regarding our portfolio stocks that you should know about. Read More

Last week Argos Therapeutics (ARGS) announced its COO was abruptly resigning and the company known for treating aggressive forms of cancer with immunotherapy would lay off 18 lab workers. The share price immediately plunged as a result, falling from more than $12 to below $8 in a matter of days.As… Read More

To make room for the new recommendations we will be adding to the Breakthrough Tech Stocks portfolio we are revising the STI portfolios as described below.Investments PortfolioThe Investments portfolio will be merged with the Smart Tech 50 portfolio since it always includes the top 10 rated stocks according to… Read More

The times are clearly changing, both in the markets and in our focus. It’s a big world and there are a lot of companies out there who do special things. Read More

It the Internet of Things weren’t reality, it would sound like the plot of a science fiction movie. Silently, and all around us, our devices are starting to talk to each other. Trading information, planning and alerting each other at crucial times.   Read More

We’re moving beyond just tech companies to a universe that covers companies swept up into, and profiting from, the information technology revolution. That revolution is spreading because of the growing power of computing, cloud, mobile and data. Read More

Its no secret that embattled Yahoo (YHOO) CEO Marissa Mayer is under the gun to prove to shareholders that she should remain in her leadership position with the company. However, in this case its not only the CEO that is under the microscope, but the company’s entire board of directors… Read More

The Fed is getting smarter, cars are getting smarter, and we're getting smarter (and richer!) right along with them. Read More

Special Situations Portfolio Update – Argos TherapeuticsFor those of you participating in our current cancer treatment play (“One Little Shot to Kill Cancer Dead“), tomorrow is an important day. One of the three stocks we recommend in that bundle – Argos Therapeutics (ARGS) – is releasing its fourth quarter… Read More

The cloud megatrend is a significant positive force for Arista Networks (ANET), a pure-play high-speed datacenter switch vendor with a focus on software. Founded in 2004, the company shipped its first product in 2008. Since then, it has become a major disruptor in the switching market. I am adding Arista… Read More

Virtual reality (VR) is on its way to becoming an important new computing platform. While still in its early stages, VR is expected to start gaining real traction this year. VR represents an entirely new tech ecosystem. Using a VR headset, it’s an immersive experience for users providing “presence” in… Read More

In this issue: The Big Picture: Is Biotech Dead Money? In Depth: New EBIS Pick:  Whitewave Foods (WWAV) – Food. Science. Momentum. Special Situation Trading Portfolio: Biotech ETF Short Term Trade Details Long Term Holding EBIS Portfolio:  VIVO News, Breakout – Updated Buy Range News and Analysis: Biosimilars:  Behind the… Read More

As we pivot into the next major long term economic cycle, the stock market is searching for a new set of companies to lead it higher and we believe it is companies such as these that will do it. Read More

Long time subscribers to Smart Tech Investor may recall our story from last June on exoskeleton technology (“From Comic Books to Reality: Exoskeletons Are Here to Stay“), which recommended three companies that are currently held in our Special Situations Portfolio: Ekso Bionics (EKSO), ReWalk Robotics (RWLK) and Parker Hannifin (PH). Read More

All three of our Special Situations Portfolio "cancer stocks" - companies that are on the cutting edge of developing revolutionary treatment for some of the worst forms of cancer, were in the news recently. And almost all of the news was good, with all three stocks moving up smartly as a result. Read More

We are adding a new portfolio that will focus on stocks that offer tremendous long-term upside potential in fast-growing sectors that require revolutionary technology. Read More

Due to last Monday’s Presidents Day holiday the stock market was open for only four days last week instead of the usual five, but that’s all the time it needed to gain nearly 3% – one of its strongest showings in 2016. In fact, after hitting its closing low of… Read More

Securing data that doesn’t easily fit into a spreadsheet is becoming more critical. Since half of all data breaches these days involve some form of unstructured data (everything from text to video images), decision-makers higher up in organizations are now much more interested in learning how to best protect critical… Read More

Travelers more than ever are demanding one-stop shopping when it comes to the online experience. Read More

The main questions for biotech investors are whether there is a correlation between the price of oil and if there is such a correlation, what is it telling us at the current period and the potential for the price action in the biotech sector? Read More